FAKTOR OPTIONSSCHEIN - AMGEN Share Price

DE000GX8KZD7

Real-time BOERSE MUENCHEN 07:55:05 27/05/2024 pm IST
2.261 ^EUR	+3.05%

Current month	+68.51%
1 month	+66.34%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart AMGEN INC.

Latest news about AMGEN INC.

Supreme Court Holds Invalid Cholesterol Drug Patent That Covered Millions Of Undisclosed Antibodies	11:45am	AQ
Amgen : An Underrecognized Risk Factor for Heart Disease	23/05	PU
Improving treatment responses to solid tumours with trispecific TCEs	23/05	AQ
Amgen : From the Office to the Lab, Amgen Uses AI Tools to Unlock Innovation	22/05	PU

More news

Quotes 5-day view

Date	Price	Change
27/24/27	2.261	+3.05%
24/24/24	2.194	-6.24%
23/24/23	2.34	-10.34%
22/24/22	2.61	-2.25%
21/24/21	2.67	-1.84%

Real-time BOERSE MUENCHEN

Last update May 27, 2024 at 07:55 pm IST

More quotes

Static data

Product type	Exotic Products
Buy / Sell	CALL
Underlying	AMGEN INC.
Issuer	Goldman Sachs
WKN	GX8KZD
ISIN	DE000GX8KZD7
Date issued	04/02/2022
Strike	268.2 $
Maturity	Unlimited
Parity	16.07 : 1
Emission price	9.91 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	30.53 €
Lowest since issue	0.846 €
Spread	0.01 €
Spread %	0.43%

Company Profile

Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows: - drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.; - other (5.8%): primarily royalties. The United States account for 70.3% of net sales.

Sector

More about the company

Ratings for Amgen Inc.

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Consensus: Amgen Inc.

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

305.8 USD

Average target price

316.3 USD

Spread / Average Target

+3.41%

Consensus